510(k) K780250
K780250 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "HEMOPEXIN NEPHELOMETRIC ASSAYS". The FDA issued a decision of Substantially Equivalent on February 28, 1978. The device falls under product code CZX (Hemopexin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5490. Kallestad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 28, 1978
- Date Received
- February 14, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hemopexin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5490
- Review Panel
- IM
- Submission Type